An advisory panel, stacked with RFK Jr.’s pro-peptide appointees, has voted to add BPC-157 and KPV to the bulk compounding list. This is despite FDA staff clinicians stating that there’s no convincing evidence. Central to the argument is whether allowing compounding will curtail the gray market or expose the public to unnecessary risk. Internally screaming.
The watches sport a new chip, bigger batteries, and new health metrics. But the updates come with another price hike.
Leonardo Del Vecchio, president of Ray-Ban and chief strategy officer at EssilorLuxottica, posted these to his Instagram story. The first is a picture of an activist ad plastered over an actual Meta Glasses ad… and the second is Del Vecchio saying, “If we can’t laugh about it why should anyone trust us?”
Legend has it that we have smart home security cameras and smartphones to thank for discovering the Seattle-based treasure that is Jimothy. At least this modern cryptid doesn’t appear to be AI slop. Happy Friday.
Secretary of Defense Pete Hegseth announced mandatory testosterone screenings, but it’s a symptom of a larger fixation.
If you are, Withings’ BodyScan 2 is available to buy starting today. Why is the scale $600? Well, it measures 60 biomarkers, and it’s positioned as a “longevity station.”
It also offers noninvasive metabolic metrics like glucose resilience via bioimpedance spectroscopy and foot sweat. Yes, foot sweat.
If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement.
watchOS 27 feels like a culmination of several years of smaller updates.
8
Verge Score
This is a smart ring for new users. Everyone else should wait until their current ring dies.
Clowning on the longevity king is fun, but it ignores why people biohack in the first place.
